Drugs, Health Regulation & Law
Insulin Price Controls, Who Falls Through the Gaps?
In the United States, 6 million people take insulin to control their type 2 diabetes. In recent years, the high price of...
Subject: Drugs
Clinical Ethics, Clinical Trials & Studies, Drugs, Editorial-AJOB
The Hopkins-Oxford Psychedelics Ethics (HOPE) Working Group Consensus Statement
The first Hopkins-Oxford Psychedelic Ethics (HOPE) workshop convened to discuss ethical matters relating to psychedelics...
Drugs, LGBTQ ethics, Public Health
To Queer(y) Addiction
Even as the opioid crisis gains increased attention in the U.S., there remains a prevalent stereotype that associates su...
Clinical Ethics, Clinical Trials & Studies, Drugs, Editorial-AJOB
From Opioid Overdose to LVAD Refusals: Navigating the Spectrum of Decisional Autonomy
The following editorial can be found in the May 2024 issue of the American Journal of Bioethics. In “Revive and Refuse: ...
Clinical Ethics, Drugs, Editorial-AJOB
Why Patients Leave: The Role of Stigma and Discrimination in Decisions to Refuse Post-Over...
The following editorial can be found in the May 2024 issue of the American Journal of Bioethics. In 2022, an estimated 1...
Clinical Ethics, Clinical Trials & Studies, Drugs
Ethical Concerns with Video Recording in Psychedelic-Assisted Therapy
Psychedelic drugs like psilocybin, LSD, MDMA, and ketamine, among others, can radically alter mood, behaviour, emotions,...
Psychedelic Ethics in a World “Warring With Drugs”
Along with apple pie, colonialism, and imperialism, one of America’s best-known characteristics known around the globe i...
Drugs
To ‘Shroom or not to ‘Shroom?: Lopsided Research And Policy Within Psychedelics Increases ...
Whether due to industry pressure, media hype, or a sense of optimism over a handful of recent clinical trials, the FDA m...
Rising Cost of Cancer Care: Perspectives & Consequences
In January 2023, we have seen biotech layoff a small percentage of their workforce citing “pressure on drug price and in...